edarbi tablet 40mg
takeda pharmaceuticals (asia pacific) pte. ltd. - azilsartan medoxomil potassium 42.68mg eqv azilsartan medoxomil - tablet - 40mg
edarbi tablet 80mg
takeda pharmaceuticals (asia pacific) pte. ltd. - azilsartan medoxomil potassium 85.36mg eqv azilsartan medoxomil - tablet - 80mg
lopresor 50mg tablet
novartis pharmaceuticals canada inc - metoprolol tartrate - tablet - 50mg - metoprolol tartrate 50mg - beta-adrenergic blocking agents
lopresor 100mg tablet
novartis pharmaceuticals canada inc - metoprolol tartrate - tablet - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents
lopresor sr 200 mg tablet (extended-release)
novartis pharmaceuticals canada inc - metoprolol tartrate - tablet (extended-release) - 200mg - metoprolol tartrate 200mg - beta-adrenergic blocking agents
lopresor sr 100mg tablet (extended-release)
novartis pharmaceuticals canada inc - metoprolol tartrate - tablet (extended-release) - 100mg - metoprolol tartrate 100mg - beta-adrenergic blocking agents
lopresor inj 1.0mg/ml solution
novartis pharmaceuticals canada inc - metoprolol tartrate - solution - 1mg - metoprolol tartrate 1mg - beta-adrenergic blocking agents
cesamet- nabilone capsule
meda pharmaceuticals - nabilone (unii: 2n4o9l084n) (nabilone - unii:2n4o9l084n) - nabilone 1 mg - cesamet capsules are indicated for the treatment of the nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. this restriction is required because a substantial proportion of any group of patients treated with cesamet can be expected to experience disturbing psychotomimetic reactions not observed with other antiemetic agents. because of its potential to alter the mental state, cesamet is intended for use under circumstances that permit close supervision of the patient by a responsible individual particularly during initial use of cesamet and during dose adjustments. cesamet contains nabilone, which is controlled in schedule ii of the controlled substances act. schedule ii substances have a high potential for abuse. prescriptions for cesamet should be limited to the amount necessary for a single cycle of chemotherapy (i.e., a few days). cesamet capsules are not intended to be used on as needed basis or as a first antieme
ocudox - doxycycline hyclate capsule
ocusoft inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline hyclate 50 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. treatment: doxycycline is indicated for the treatment of the following infections: - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae. - lymphogranuloma venereum caused by chlamydia trachomatis. - psittacosis (ornithosis) caused by chlamydia psittaci. - trachoma caused by chlamydia trachomatis, although the infectious agent is not
perrigo prednisone tablet
perrigo pharmaceuticals company - prednisone (unii: vb0r961hzt) (prednisone - unii:vb0r961hzt) - prednisone 10 mg